Moreover, overexpression of sphingomyelin synthase 1, a key enzyme that converts ceramides into sphingomyelins, downregulates TβRI expression and thus impairs TGF-β-induced EMT in breast cancer cell lines (Liu et al., 2019). Here, TGFB1 is linked to breast cancer.